Gustavo A. Nores
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gustavo A. Nores has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
A.M. Villa
División Neurologı́a, Hospital Ramos Mejı́a, Buenos Aires, Argentina
1 shared publication- Andrés Maria Villa
Neuroinmunology Section, Neurology, Hospital J.M. Ramos Mejía, Buenos Aires, Argentina; University Centre of Neurology, Faculty of Medicine, Buenos Aires University, Argentina
1 shared publication Gustavo Sevlever
1 shared publicationMaría E. Alaniz
Departamento de Química Biológica Dr. Ranwel Caputto, CIQUIBIC, CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina
1 shared publicationMaría I. Farace
Servicio Bacteriología Sanitaria, Instituto Nacional de Enfermedades Infecciosas, Administración Nacional de Laboratorios e Institutos de Salud “Carlos G. Malbran,” Buenos Aires, Argentina
1 shared publicationP.H.H. Lopez
Departamento de Química Biológica "Dr. Ranwel Caputto", Facultad de Ciencias Químicas, Universidad Nacional de Córdoba (UNC) and CIQUIBIC, CONICET, Ciudad Universitaria, 5000, Córdoba, Argentina
1 shared publication
Latest Publications
- Open Access
- 1 April 2004
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (4) , 2148-2151
Normally Occurring Human Anti-GM1Immunoglobulin M Antibodies and the Immune Response to Bacteria
Anti-GM1antibodies of the immunoglobulin M (IgM) isotype are normal components of the antibody repertoire of adult human serum. Using a sensitive high-performance thin-layer chromatography (HPTLC) immunostaining assay, we found that these antibodies were absent in the umbilical vein and children 1IgM antibodies showed a perfect concordance with two well-characterized antibacterial antibodies, anti-Forssman and anti-blood group A, which indicates a similar origin. We also studied IgM reactivity with lipopolysaccharides (LPSs) from gram-negative bacteria isolated from stool samples from healthy babies and fromEscherichia coliHB101 in serum from individuals of different ages. We found a positive reaction with both LPSs in all the children more than 1 month of age analyzed, even in those that were negative for anti-GM1antibodies. Anti-GM1IgM antibodies were purified from adult serum by affinity chromatography and tested for the ability to bind LPSs from different bacteria. This highly specific preparation showed reactivity only with LPS from a strain ofCampylobacter jejuniisolated from a patient with diarrhea. We conclude that normally occurring IgM antibodies are generated after birth, probably during the immune defense against specific bacterial strains.
- 1 April 2004
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (4) , 2148-2151
Open AccessNormally Occurring Human Anti-GM1Immunoglobulin M Antibodies and the Immune Response to Bacteria
Anti-GM1antibodies of the immunoglobulin M (IgM) isotype are normal components of the antibody repertoire of adult human serum. Using a sensitive high-performance thin-layer chromatography (HPTLC) immunostaining assay, we found that these antibodies were absent in the umbilical vein and children 1IgM antibodies showed a perfect concordance with two well-characterized antibacterial antibodies, anti-Forssman and anti-blood group A, which indicates a similar origin. We also studied IgM reactivity with lipopolysaccharides (LPSs) from gram-negative bacteria isolated from stool samples from healthy babies and fromEscherichia coliHB101 in serum from individuals of different ages. We found a positive reaction with both LPSs in all the children more than 1 month of age analyzed, even in those that were negative for anti-GM1antibodies. Anti-GM1IgM antibodies were purified from adult serum by affinity chromatography and tested for the ability to bind LPSs from different bacteria. This highly specific preparation showed reactivity only with LPS from a strain ofCampylobacter jejuniisolated from a patient with diarrhea. We conclude that normally occurring IgM antibodies are generated after birth, probably during the immune defense against specific bacterial strains.
- 1 July 2002
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 128 (1-2) , 69-76
High affinity as a disease determinant factor in anti-GM1 antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies
- 1 July 2002
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 128 (1-2) , 69-76
High affinity as a disease determinant factor in anti-GM1 antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies
- 1 January 2002
- Vol. 62 (3) , 237-40
Antiganglioside antibodies in serum of patients with chronic sensory ataxic neuropathy.
Recent studies have shown that antiganglioside antibodies, particularly those associated with the disialosyl group, may be involved in immune-mediated sensory peripheral neuropathies. We report the results of plasma screening for antiganglioside antibodies in two patients with chronic ataxic neuropathy. We found reactivity against gangliosides GD3, GD1b, and GT1b in one of them and against GD1a in the other, even though both had nearly identical clinical pictures. Results suggest that anti-GD1a antibodies, which are usually associated with motor polyneuropathy, may also be involved in the pathogenesis of clinically pure sensory polyneuropathy.
- 1 January 2002
- Vol. 62 (3) , 237-40
Antiganglioside antibodies in serum of patients with chronic sensory ataxic neuropathy.
Recent studies have shown that antiganglioside antibodies, particularly those associated with the disialosyl group, may be involved in immune-mediated sensory peripheral neuropathies. We report the results of plasma screening for antiganglioside antibodies in two patients with chronic ataxic neuropathy. We found reactivity against gangliosides GD3, GD1b, and GT1b in one of them and against GD1a in the other, even though both had nearly identical clinical pictures. Results suggest that anti-GD1a antibodies, which are usually associated with motor polyneuropathy, may also be involved in the pathogenesis of clinically pure sensory polyneuropathy.